BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leung MS, Chan KK, Dai WJ, Wong CY, Au KY, Wong PY, Wong CC, Lee TK, Ng IO, Kao WJ, Lo RC. Anti-tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma. J Pathol 2020;252:65-76. [PMID: 32558942 DOI: 10.1002/path.5492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Cheng DH, Lai KD, Su H, Lu GS, Wang L, Lv JH. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1. Drug Des Devel Ther 2021;15:4885-99. [PMID: 34880599 DOI: 10.2147/DDDT.S327270] [Reference Citation Analysis]
2 Liang X, Zhou R, Li Y, Yang L, Su M, Lai KP. Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease. Aging (Albany NY) 2021;13:15785-800. [PMID: 34176789 DOI: 10.18632/aging.203220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]